Antibody-dependent cellular cytotoxicity in systemic lupus erythematosus. 1977

I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi

Antibody-dependent cellular cytotoxicity of peripheral blood mononuclear cells from fourty-six patients with systemic lupus erythematosus was found to be reduced in two independent test systems. The percentage decrease in cytotoxicity was similar in the tests with allogeneic and xenogeneic targets and it was related to the activity of systemic lupus erythematosus.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell

Related Publications

I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
July 1985, Journal of clinical & laboratory immunology,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
March 1984, Journal of clinical & laboratory immunology,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
May 1975, Clinical and experimental immunology,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
August 1983, The Journal of rheumatology,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
February 1981, Annals of the rheumatic diseases,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
November 1978, Clinical and experimental immunology,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
December 1982, Annals of the rheumatic diseases,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
February 1975, Nihon Jinzo Gakkai shi,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
January 1982, The Journal of rheumatology,
I Láng, and B Fekete, and K Pálóczi, and I Sonkoly, and G Szegedi, and K Török, and P Gergely, and G Petrányi
November 1980, Arthritis and rheumatism,
Copied contents to your clipboard!